The impact of plasma triglyceride and apolipoproteins concentrations on high-density lipoprotein subclasses distribution.
OBJECTIVE
To investigate the effect of triglyceride (TG) integrates with plasma major components of apolipoproteins in HDL subclasses distribution and further elicited the TG-apolipoproteins (apos) interaction in the processes of high density lipoprotein (HDL) mature metabolic and atherosclerosis related diseases.


METHODS
Contents of plasma HDL subclasses were quantities by two-dimensional gel electrophoresis associated with immunodetection in 500 Chinese subjects.


RESULTS
Contents of preβ1-HDL, HDL3a, and apoB-100 level along with apoB-100/A-I ratio were significantly increased, whereas there was a significant reduction in the contents of HDL2, apoA-I level as well as apoC-III/C-II ratio with increased TG concentration. Moreover, preβ1-HDL contents is elevated about 9 mg/L and HDL2b contents can be reduced 21 mg/L for 0.5 mmol/L increment in TG concentration. Moreover, with increase of apoA-I levels, HDL2b contents were marginally elevated in any TG concentration group. Furthermore, despite of in the apoB-100/A-I < 0.9 group, the contents of preβ1-HDL increased, and those of HDL2b decreased significantly for subjects in both high and very high TG levels compared to that in normal TG levels. Similarly, in the apoB-100/A-I ≥ 0.9 group, the distribution of HDL subclasses also showed abnormality for subjects with normal TG levels.


CONCLUSIONS
The particle size of HDL subclasses tend to small with TG levels increased which indicated that HDL maturation might be impeded and efficiency of reverse cholesterol transport(RCT) might be weakened. These data suggest that TG levels were not only significantly associated with but liner with the contents of preβ1-HDL and HDL2b. They also raise the possibility that the TG levels effect on HDL maturation metabolism are subjected to plasma apolipoproteins and apolipoproteins ratios.
Laboratory of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
Li
L
Tian
Yanhua
Y
Xu
Mingde
M
Fu
Tao
T
Peng
Yinghui
Y
Liu
Shiyin
S
Long
D001053:Apolipoproteins / Q000097:blood*; D016022:Case-Control Studies; D005260:Female; D053442:High-Density Lipoproteins, Pre-beta / Q000097:blood* / Q000737:chemistry; D006801:Humans; D053439:Lipoproteins, HDL2 / Q000097:blood* / Q000737:chemistry; D008297:Male; D008875:Middle Aged; D010316:Particle Size; D014280:Triglycerides / Q000097:blood*
D001053:Apolipoproteins; D053442:High-Density Lipoproteins, Pre-beta; D053439:Lipoproteins, HDL2; D014280:Triglycerides
Clin Chim Acta. 2003 Jun;332(1-2):95-102
12763286
Ann Med. 2006;38(3):229-38
16720437
Nat Clin Pract Cardiovasc Med. 2006 Mar;3(3):144-53
16505860
Lipids Health Dis. 2010 Sep 23;9:104
20863394
Biochemistry. 1973 Apr 24;12(9):1828-33
4349259
J Lipid Res. 2009 Feb;50(2):183-92
18787236
Arthritis Res Ther. 2004;6(6):R563-6
15540281
Eur Heart J. 1998 Oct;19 Suppl M:M8-14
9821011
Crit Care Med. 2004 Mar;32(3):632-7
15090939
Diabetes Care. 2009 Apr;32(4):695-701
19131468
Clin Chem. 1985 Feb;31(2):217-22
2578337
Clin Chem. 1990 Apr;36(4):591-7
2182220
Arterioscler Thromb. 1991 Jan-Feb;11(1):174-82
1987996
Atherosclerosis. 1999 Aug;145(2):227-38
10488948
Biochemistry. 2006 Feb 21;45(7):2408-13
16475830
N Engl J Med. 1980 Jun 19;302(25):1383-9
7374696
Stroke. 2004 Oct;35(10):2248-52
15345795
Int J Cardiol. 2007 Sep 3;120(3):331-7
17166608
Atherosclerosis. 1983 Mar;46(3):341-52
6847745
Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):406-10
16306426
Am Heart J. 2005 Nov;150(5):1039-45
16290993
Am J Cardiol. 1998 Feb 26;81(4A):7B-12B
9526807
Clin Chem. 1972 Jun;18(6):499-502
4337382
Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2181-7
15388521
J Lipid Res. 1995 Feb;36(2):211-28
7751809
Lancet. 1975 Jan 4;1(7897):16-9
46338
Clin Chim Acta. 2005 Apr;354(1-2):49-58
15748599
J Lipid Res. 2004 Jul;45(7):1169-96
15102878
J Lipid Res. 1991 Mar;32(3):383-94
1906084
Clin Chem. 1986 Jan;32(1 Pt 1):142-5
3940695
Lancet. 2001 Dec 15;358(9298):2026-33
11755609
JAMA. 2001 May 16;285(19):2486-97
11368702
Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):434-8
1703299
J Lipid Res. 2001 Dec;42(12):2007-14
11734573
Curr Opin Lipidol. 1996 Aug;7(4):209-16
8883496
Lancet. 2004 Sep 11-17;364(9438):937-52
15364185
Biochim Biophys Acta. 2000 Dec 15;1529(1-3):245-56
11111093
Am J Cardiol. 1998 Feb 26;81(4A):18B-25B
9526809
Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):897-902
16469947
Biochem Soc Trans. 2003 Oct;31(Pt 5):1066-9
14505481
Curr Opin Lipidol. 1994 Dec;5(6):404-16
7712045
Clin Chim Acta. 2008 Feb;388(1-2):148-55
18036560